tiprankstipranks
Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ:BDTX
US Market
BDTX
Black Diamond Therapeutics
RESEARCH TOOLSreports
Want to see BDTX full AI Analyst Report?

Black Diamond Therapeutics (BDTX) Income Statement

1,601 Followers

Black Diamond Therapeutics Income Statement

Last quarter (Q4 2025), Black Diamond Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Black Diamond Therapeutics's net income was $-15.12M. See Black Diamond Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 70.00M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 69.67M$ 0.00$ -437.00K$ 0.00$ 0.00
Operating Expenses
$ 49.80M$ 78.78M$ 86.02M$ 92.83M$ 126.87M
Depreciation and Amortization
$ 325.00K$ 343.00K$ 437.00K$ 508.00K$ 205.00K
EBITDA
$ 20.20M$ -78.44M$ -86.02M$ -92.32M$ -126.67M
Operating Income
$ 19.87M$ -78.78M$ -86.46M$ -92.83M$ -126.87M
Other Income/Expenses
$ 2.50M$ 9.11M$ 4.02M$ 1.66M$ 1.28M
Pretax Income
$ 22.37M$ -69.68M$ -82.44M$ -91.17M$ -125.60M
Net Income
$ 22.37M$ -69.68M$ -82.44M$ -91.17M$ -125.60M
Per Share Metrics
Basic EPS
$ 0.39$ -1.27$ -1.88$ -2.52$ -3.47
Diluted EPS
$ 0.39$ -1.27$ -1.88$ -2.52$ -3.47
Weighted Average Shares Outstanding
 56.87M 55.03M 43.95M 36.23M 36.19M
Weighted Average Shares Outstanding (Diluted)
 57.56M 55.03M 43.95M 36.23M 36.19M
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History